Ron Zwanziger is CEO, Chairman, and Director of LumiraDx, a company he co-founded in 2014 which develops, manufactures, and commercializes an innovative point-of-care diagnostic Platform. The LumiraDx Platform delivers lab comparable diagnostic results at the point of care in minutes and is designed to be affordable and accessible to strengthen community-based healthcare.
A strategic visionary and entrepreneur, Ron previously built and has been Chairman and CEO of several leading diagnostic companies including Alere, Inverness Medical Technology (right up to its acquisition by Johnson & Johnson in 2001) and MediSense - the first company to launch an electrochemical glucose sector. He currently serves on the Board of Directors of several private companies
What is the biggest thing you learned in 2020?
What do you feel are the two most important benefits or areas that need to be a top priority in 2021?
Can you share a story on an area of your healthcare program or employee benefits where you were able to create significant savings or stop costs from rising?
If you could automatically receive a 10-20% reduction in costs in three areas/programs, what would your dream list be?
What is the most innovative program you will focus on in 2021 and/or 2022?
How are you re-imagining corporate culture & well-being?
What virtual care solutions did you roll out during the pandemic? How valuable were they and why?
If you look at our 3 Moonshots - Costs, Culture, and Care; In one sentence, tell us what would be something positive for us to take from 2020 and bring into this new year?